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Summary
 
Interferon (IFN)-
 
g
 
, a key immunoregulatory cytokine, has been thought to be produced solely
by activated T cells and natural killer cells. In this study, we show that murine bone marrow–
derived macrophages (BMM
 
F
 
) secrete large amounts of IFN-
 
g
 
 upon appropriate stimulation.
Although interleukin (IL)-12 and IL-18 alone induce low levels of IFN-
 
g
 
 mRNA transcripts,
the combined stimulation of BMM
 
F
 
 with both cytokines leads to the efficient production of
IFN-
 
g
 
 protein. The macrophage-derived IFN-
 
g
 
 is biologically active as shown by induction of
inducible nitric oxide synthase as well as upregulation of CD40 in macrophages. Our findings
uncover a novel pathway of autocrine macrophage activation by demonstrating that the mac-
rophage is not only a key cell type responding to IFN-
 
g
 
 but also a potent IFN-
 
g
 
–producing
cell.
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I
 
nterferon (IFN)-
 
g
 
 regulates a variety of important im-
munological programs. It is the predominant cytokine
during Th1-dominated immune reactions, participates im-
portantly during antigen presentation, and is the prototypi-
cal macrophage-activating cytokine. Consequently, a piv-
otal role of IFN-
 
g
 
 in the clearance of various intracellular
pathogens has been amply demonstrated (1). One of the
key events during innate immune reactions is the produc-
tion of IL-12 mainly by macrophages (2). IL-12 induces
NK cells to rapidly secrete IFN-
 
g
 
, which then acts back to
activate macrophages early in an immune response. Fur-
thermore, IL-12 induces IFN-
 
g
 
 production by T cells and
is the key cytokine driving Th1 cell differentiation.
A recently discovered novel cytokine, IL-18, shares many
functional properties with IL-12. IL-18 was described orig-
inally as a Kupffer cell–derived costimulating factor essen-
tial for the production of IFN-
 
g
 
 in a murine LPS–induced
shock model (3). IL-18 has been cloned recently (4), and
was shown subsequently to induce IFN-
 
g
 
 in human (5)
and murine (6) T cells. Moreover, strong synergistic effects
between IL-12 and IL-18 in the induction of IFN-
 
g
 
 secre-
tion of T cells (5, 6) or NK cells (7) were described.
A few reports described the secretion of low levels of
IFN-
 
g
 
 by murine (8, 9) or human (10) macrophages stimu-
lated with IFN-
 
g
 
 itself (8), IL-12 (9), or 
 
Mycobacterium tu-
berculosis 
 
(10). Because these findings are at variance with
the widely accepted view that T cells and NK cells are the
sole producers of IFN-
 
g
 
, the general significance of these
observations remained uncertain. A recent report demon-
strated the secretion of IFN-
 
g
 
 even by B cells upon com-
bined stimulation with IL-12 and IL-18 (11). In this study,
we demonstrate that these two cytokines synergistically in-
duce macrophages to secrete large amounts of IFN-
 
g
 
which is biologically active in an autocrine fashion
 
.
 
 The
data suggest that macrophage activation may operate by an
autocrine positive feedback loop involving multiple cyto-
kines, including IFN-
 
g
 
.
 
Materials and Methods
 
Medium and Reagents.
 
All cell culture was performed in DMEM
supplemented with 10% heat-inactivated FCS, 2 mM 
 
l
 
-glutamine,
60 
 
m
 
M 2-mercaptoethanol, 1 mM sodium pyruvate, 1
 
3
 
 nones-
sential amino acids, 100 U/ml penicillin, and 100 
 
m
 
g/ml strepto-
mycin (GIBCO BRL, Paisley, UK).
Recombinant murine IFN-
 
g
 
 was obtained from Genentech
Inc. (South San Francisco, CA), IL-12 was purchased from R&D
Systems (Abingdon, UK), and IL-18 and TNF-
 
a
 
 from Pepro-
Tech, Inc. (London, UK). Biotinylated anti-CD40 (clone 3/23)
and rIgG2a isotype control antibodies were obtained from
PharMingen (San Diego, CA). Streptavidin-PE was purchased
from GIBCO BRL.
 
Animals and Generation of Bone Marrow–derived Macrophages.
 
Mice of strains AKR/N, C57BL/6, and 129Sv and mice ho-
mozygous for a targeted mutation of the IFN-
 
g
 
 receptor (IFN-
 
g
 
R
 
2
 
/
 
2
 
; 129Sv) (12) were obtained from the specific pathogen–
free animal facilities of the Max-Planck-Institut and were used
between 6 and 8 wk of age.
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Interferon 
 
g
 
 Secretion of Macrophages
Macrophages were derived from bone marrow cells (
 
BMM
 
F
 
)
as described previously (12).
 
IFN-
 
g
 
 Assay, Nitric Oxide Measurement, and Analysis of CD40
Expression by FACS
 
Ò
 
.
 
IFN-
 
g
 
 was determined by a commer-
cially available (PharMingen) sandwich ELISA test according to
the manufacturer’s protocol. The measuring range of the ELISA
test was 0.5–100 ng/ml. Nitric oxide (NO) was measured as ni-
trite using the Griess reagent as described previously (13).
To assess CD40 expression by FACS
 
Ò
 
, 2 
 
3
 
10
 
5
 
 BMM
 
F
 
 were
preincubated with FcBlock
 
TM
 
 (PharMingen) and stained with bi-
otinylated anti-CD40 mAb or isotype control (biotin rIgG2a) for
30 min on ice. After another wash step, cells were stained with
Streptavidin-PE for 30 min on ice and subsequently analyzed on a
FACScan
 
Ò
 
 (Becton Dickinson, Mountain View, CA), gating on
viable cells by propidium iodide counterstaining. All washing and
staining steps were performed in PBS/2% FCS.
 
Reverse Transcription PCR.
 
5 
 
3
 
 10
 
6
 
 BMM
 
F
 
 were seeded and
stimulated in 55-mm Petriperm
 
Ò
 
 hydrophob Petri dishes (Heraeus
GmbH, Hanau, Germany) in a final volume of 5 ml. At the indi-
cated time points, cells were harvested with a rubber policeman,
and total cellular RNA was prepared by the method of Chom-
czynski and Sacchi (14). Reverse transcription was performed by
standard procedures using Moloney murine leukemia virus re-
verse transcriptase (Pharmacia GmbH, Freiburg, Germany).
0.01–1 
 
m
 
l of the resulting cDNA (adjusted to a concentration
of 50 ng/
 
m
 
l input RNA) was then amplified by PCR (annealing
temperature 58
 
8
 
C, 1.5 mM MgCl
 
2
 
) for 35 cycles. The sequences
for the primers used are as follows: 
 
b
 
-actin sense primer, 5
 
9
 
 TG-
GAATCCTGTGGCATCCAT GAAAC 3
 
9
 
, and 
 
b
 
-actin anti-
sense primer, 5
 
9
 
 TAAAACGCAGCTCAGTAACAGTCCG 3
 
9
 
,
generating a 348-bp PCR product; and IFN-
 
g
 
 sense primer, 5
 
9
 
GCTCTGAGACAATGAACGCT 3
 
9
 
, and IFN-
 
g
 
 antisense
primer, 5
 
9
 
 AAAGAGATAATCTGGCTCTGC 3
 
9
 
, generating a
227-bp PCR product. The PCR products were run on a 1.5%
agarose gel and visualized by ethidium bromide staining.
 
RNA In Situ Hybridization.
 
In situ hybridization was performed
using a digoxigenin-labeled riboprobe corresponding to the region
between nucleotides 371 and 1075 of the mouse 
 
IFN
 
-
 
g
 
 cDNA,
using a protocol modified from Vignaud et al. (15). In brief, BMM
 
F
 
were cultured on glass chamber slides (Nunc, Inc., Naperville, IL),
washed in PBS, fixed in 4% paraformaldehyde for 3 min, perme-
abilized in 100 mM glycine for 20 min, followed by a short wash
in water, and postfixed in 4% paraformaldehyde for 5 min. The
cells were then hybridized overnight at 55
 
8
 
C with 1 
 
m
 
g/ml of
the riboprobe in 40% formamide, 5
 
3
 
 SSC, 1
 
3
 
 Denhardt’s, 100
 
m
 
g/ml denatured herring sperm DNA, and 100 
 
m
 
g/ml tRNA. After
extensive washing in 2
 
3
 
 SSC, 50% formamide at 50
 
8
 
C, unspecific
antibody binding was blocked by incubation at room temperature
for 1 h in TBS (25 mM Tris-HCl, pH 7.5, 140 mM NaCl, 2.7
mM KCl) containing 10% sheep serum. Alkaline phosphatase–con-
jugated antidigoxigenin antibodies (Boehringer Mannheim, Mann-
heim, Germany) were then applied at 4
 
8
 
C for 5 h in TBS containing
1% sheep serum. The cells were then washed extensively in TBS,
equilibrated with 100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50
mM MgCl
 
2
 
, and the alkaline phosphatase activity was developed
with BCIP/NBT (Boehringer Mannheim) for 6 h. The prepara-
tions were mounted, and the cells were photographed under
Nomarski optics.
 
Results
 
IL-12 and IL-18 Stimulate BMM
 
F
 
 to Secrete Large Amounts
of IFN-
 
g
 
.
 
AKR/N-BMM
 
F
 
 were stimulated with various
 
concentrations of IL-12 or IL-18 alone or in combination
(Fig. 1). At different time points, the IFN-
 
g
 
 concentrations in
the supernatants were determined by ELISA. The stimulation
of the macrophages with IL-12 or IL-18 alone did not result
in detectable IFN-
 
g
 
 secretion. In sharp contrast, both cyto-
kines synergized strongly to induce readily detectable levels
of IFN-
 
g
 
 in the supernatants at all time points tested. The
cytokine accumulated from 3.7 ng/ml per 10
 
5
 
 cells at 24 h
to 42 ng/ml per 10
 
5
 
 cells IFN-
 
g
 
 at 96 h. Stimulation of the
macrophages with IL-12 and IL-18 at 96 h was still subopti-
mal, as a plateau of IFN-
 
g
 
 secretion has not been reached.
The induced levels of IFN-
 
g
 
 are comparable to those
reached upon anti-CD3 stimulation of the prototypical
Th1 T cell clone AE7 (81 ng/ml per 10
 
5
 
 cells, data not
shown). The ability of the macrophages to secrete IFN-
 
g
 
 is
not restricted to the AKR/N strain of mice. We also tested
BMM
 
F
 
 of C57BL/6 (see also Fig. 3 
 
A
 
) and BALB/c (data
not shown) mice with similar results. To demonstrate the
purity of our BMM
 
F
 
 population and to exclude the possi-
bility of contaminating NK, T, or B cells in our assay, we
analyzed the BMM
 
F
 
 by FACS
 
Ò
 
. The population was con-
sistently found to be homogeneously positive for F4/80,
MAC-1, I-A
 
k
 
, B7.1, and CD16/32. T cell antigens (CD3,
CD4, and CD8), NK cell marker (DX5, and also NK1.1
for C57BL/6 mice) or B cell antigens (B220, CD19, and
CD5) were uniformly negative (data not shown).
We also assayed the commonly used mouse macrophage
cell lines RAW 264.7, J774, RAW 309Cr, P388D1, and
IC 21. In contrast to BMM
 
F
 
, none of the five cell lines
produced IFN-
 
g
 
 upon stimulation with IL-12 and IL-18
(data not shown).
 
IL-12 and IL-18 Induce IFN-
 
g
 
 mRNA in BMM
 
F
 
.
 
To
address the level of regulation of IFN-
 
g
 
 synthesis, we stim-
ulated BMM
 
F with IL-12 (10 ng/ml) or IL-18 (50 ng/
ml), alone or in combination, and prepared mRNA after 2,
8, and 24 h of stimulation. IFN-g mRNA expression was
then evaluated by reverse transcription (RT)-PCR (Fig. 2
A). In the case of BMMF stimulated with IL-12 plus IL-
18, a prominent band of IFN-g mRNA appeared as early
as 2 h after addition of the cytokines, and increased further
at later time points after stimulation. The PCR product
Figure 1. IL-12/IL-18–induced IFN-g synthesis of BMMF. 105
AKR/N-BMMF were stimulated in a final volume of 200 ml in 96-well
flat-bottomed plates with increasing concentrations of IL-12 alone
(squares, no IL-12; circles, 0.001 ng/ml; triangles, 0.1 ng/ml; diamonds, 10
ng/ml), IL-18 alone, or both cytokines together in a final volume of 200 ml
in 96-well flat-bottomed plates. At the indicated time points, culture su-
pernatants were harvested and analyzed for IFN-g concentration by
ELISA. Data represent means of triplicate with SD indicated. Similar re-
sults were obtained in a total of three independent experiments.2105 Munder et al. Brief Definitive Report
was proven to result from IFN-g mRNA by sequencing
(data not shown). Surprisingly, although no secreted IFN-g
was detectable in the supernatant of BMMF stimulated
with IL-12 alone or IL-18 alone, IFN-g mRNA was
clearly induced. This induction appears to be more promi-
nent in the case of stimulation with IL-12 than with IL-18
and increases over time during the culture period. Never-
theless, as shown semiquantitatively by titrating the input
cDNA of the PCR reaction, the induction of IFN-g
mRNA by combined stimulation with IL-12 and IL-18 is
clearly far more efficient, consistent with the synergism ob-
served at the protein level. To estimate the frequency of
IFN-g–producing macrophages within the whole popula-
tion, we performed RNA in situ hybridization experiments
(Fig. 2, B and C). After 18 h of stimulation with IL-12 plus
IL-18, z25–30% of the BMMF stained strongly positive
for IFN-g mRNA (Fig. 2 C), whereas unstimulated con-
trol BMMF were homogeneously negative (Fig. 2 B).
Control stainings with the riboprobe in sense orientation
also yielded completely negative results (data not shown).
Autocrine Macrophage Stimulation by Macrophage-derived
IFN-g. To test the biological activity of IFN-g produced
endogenously by BMMF stimulated with IL-12 plus IL-
18, we tested two different indicators of IFN-g–mediated
macrophage activation. First, IFN-g is known to synergize
with TNF-a in the induction of inducible NO synthase
(iNOS) with concomitant production of nitric oxide (NO)
in macrophages (16). Therefore, we stimulated BMMF of
AKR/N and C57BL/6 mice with optimal concentrations
of IL-12, IL-18, or IL-12 plus IL-18 and titrated increasing
concentrations of TNF-a into these cultures. Control cul-
tures received IFN-g. As a readout for iNOS induction,
we determined nitrite, the stable end product of NO, in
the supernatants after 96 h of stimulation (Fig. 3 A). IFN-g
was measured simultaneously in the supernatants. In mac-
rophages exposed to IL-12 plus IL-18, increasing concen-
trations of TNF-a induced iNOS very efficiently, although
somewhat less than upon optimal stimulation with exoge-
nously added IFN-g. Experiments with mice lacking the
IFN-g receptor (IFN-gR2/2) proved that endogenously
produced IFN-g is responsible for the induction of iNOS:
although IFN-gR2/2-BMMF stimulated with IL-12 plus
IL-18 plus TNF-a secreted IFN-g comparable to control
IFN-gR1/1-BMMF (129Sv), no nitrites were detectable
in the supernatant of the IFN-gR2/2-BMMF, reflecting a
failure of iNOS induction when IFN-g is unable to signal
via its receptor (Fig. 3 B). Indeed, nitrite accumulation re-
flected iNOS induction, as demonstrated by the addition of
the iNOS inhibitor l-monomethyl-l-arginine, which com-
pletely  abolished detectable nitrites without influencing
IFN-g induction (data not shown).
Two additional interesting observations were consis-
tently made. First, with increasing concentrations of TNF-a,
IFN-g levels stimulated with IL-12 plus IL-18 decrease
(Fig. 3, A and B). IFN-gR2/2-BMMF are an exception to
this rule (Fig. 3 B), pointing to a possible role of enhanced
consumption of IFN-g upon increasing concentrations of
TNF-a. The phenomenon is unrelated to the simulta-
neously produced NO, known to be potentially autotoxic
to the secreting macrophage itself (16), because l-mono-
methyl-l-arginine had no influence on the observed de-
crease of IFN-g (data not shown). Second, in the case of
the C57BL/6-BMMF (Fig. 3 A), IL-12 alone synergizes
with TNF-a to induce IFN-g as well as iNOS. In AKR/N
mice, a different and/or less efficient synergism seems to
operate: in five independent experiments, a slight induction
of nitrites was noted consistently upon costimulation with
50 ng/ml TNF-a, whereas IFN-g in the supernatant was
either undetectable or only marginally elevated (e.g., 1.5
ng/ml in Fig. 3 A).
As a second system to demonstrate the functional potential
of the BMMF-derived IFN-g, we assayed the IFN-g–medi-
ated upregulation of CD40. Resting BMMF are negative
or only slightly positive for CD40, whereas stimulation
with IFN-g for 48 h leads to an upregulation of this co-
stimulatory molecule (M. Munder, unpublished observa-
Figure 2. IL-12/IL-18–induced IFN-g mRNA in BMMF. (A) 5 3
106 AKR/N-BMMF were seeded in 55-mm PetripermÒ hydrophob
plates and either cultivated in medium alone (control, ø) or stimulated
with 10 ng/ml IL-12 alone, 50 ng/ml IL-18 alone, or with both cytokines
together. At the indicated time points, cells were harvested, mRNA was
extracted, and cDNA was prepared as described in Materials and Meth-
ods. 1, 0.2, or 0.04 ml of input cDNA was amplified by PCR with IFN-
g–specific primers. As a control, b-actin mRNA was also amplified with 0.01
ml input cDNA. One of three independent experiments, yielding identi-
cal results, is shown. (B and C) 106 AKR/N-BMMF were cultivated on
glass chamber slides with medium alone (B) or with 10 ng/ml IL-12 plus
50 ng/ml IL-18 (C). After 18 h, RNA in situ hybridization for IFN-g
mRNA was performed as described in Materials and Methods; 3200.2106 Interferon g Secretion of Macrophages
tion). The same induction was noted on IFN-gR1/1-
BMMF (129Sv) stimulated with IL-12 plus IL-18. Again,
endogenously produced IFN-g was responsible for this ef-
fect, as demonstrated by the lack of CD40 induction on
IFN-gR2/2-BMMF stimulated with IL-12 plus IL-18
(Fig. 4). BMMF of mice with 129 background are defini-
tively less efficient in IFN-g production upon IL-12/IL-18
stimulation (Fig. 3 B, and Fig. 4) than BMMF of strains
AKR/N or C57BL/6 (Fig. 1, and Fig. 3 A). Nevertheless,
even these lower amounts of induced IFN-g clearly auto-
activate the macrophages to upregulate iNOS and CD40.
Discussion
These experiments were stimulated by the results of sev-
eral authors showing synergism between IL-12 and IL-18
in the induction of IFN-g by human (5) and murine (6) T
cells and murine NK cells (7). Remarkably, both cytokines
were shown recently to cooperatively induce IFN-g secre-
tion of murine B cells (11). We now extend these observa-
tions by demonstrating that macrophages become efficient
IFN-g–producing cells upon combined stimulation with
IL-12 and IL-18. The levels of IFN-g were of a similar
magnitude as that produced by T cells, and we observe effi-
cient autocrine macrophage activation by endogenously
generated IFN-g in vitro.
We found that a considerable proportion but not all
BMMF express IFN-g mRNA under our conditions of in
vitro stimulation. Moreover, five established macrophage
cell lines failed to produce IFN-g under these conditions.
A detailed comparison (17) of various IFN-g–induced acti-
vation parameters between immortalized macrophage cell
lines and ex vivo–derived peritoneal macrophages demon-
Figure 3. Endogenously produced IFN-g induces autocrine macrophage
stimulation: iNOS induction. (A) 105 AKR/N-BMMF were cultivated
in a final volume of 200 ml in 96-well flat-bottomed plates with medium
alone (filled squares) or stimulated with 10 ng/ml IL-12 alone (circles), 50
ng/ml IL-18 alone (triangles), with both cytokines together (diamonds), or
with 10 ng/ml IFN-g (open squares) in a final volume of 200 ml in 96-well
flat-bottomed plates. To allow for synergistic iNOS induction, increasing
concentrations of TNF-a were titrated into each culture. After 96 h, su-
pernatants were harvested, and IFN-g as well as nitrites were determined
as described in Materials and Methods. Data represent means of triplicate
with SD indicated. Similar results were obtained in a total of four inde-
pendent experiments. (B) 105 BMMF of IFN-gR1/1 (129Sv) or IFN-
gR2/2 strains of mice were stimulated with increasing concentrations of
IL-12 plus IL-18 (squares, no cytokines; circles, 0.1/0.5 ng/ml; triangles, 1/
5 ng/ml; diamonds, 10/50 ng/ml, respectively) in a final volume of 200 ml
in 96-well flat-bottomed plates. Increasing concentrations of TNF-a
were titrated into each culture. After 96 h, supernatants were harvested,
and IFN-g as well as nitrites were determined as described in Materials
and Methods. Data represent means of triplicate with SD indicated. One
of two independent experiments with similar results is shown.
Figure 4. Macrophage-derived IFN-g is biologically active: CD40 up-
regulation. 1.5 3 106 BMMF of IFN-gR1/1 (129Sv) or IFN-gR2/2
strains of mice were seeded in 35-mm PetripermÒ hydrophob plates in a
final volume of 1.5 ml. They were either not stimulated (ø, medium only)
or stimulated with 10 ng/ml IFN-g (positive control) or with the combi-
nation of 10 ng/ml IL-12 plus 50 ng/ml IL-18. After 48 h, BMMF were
harvested with a rubber policeman and analyzed by FACSÒ for CD40 up-
regulation as described in Materials and Methods. (*) Simultaneous deter-
mination of IFN-g concentration (ng/ml) in the 48-h supernatant. ND,
Not determined. One of two independent experiments with similar re-
sults is shown.2107 Munder et al. Brief Definitive Report
strated that each immortalized cell line exhibited only a
part of the spectrum of the determined activation markers,
whereas all were detected in normal macrophages. It is not
clear whether these and our findings reflect a genuine
quantitative or qualitative macrophage heterogeneity in the
response to cytokines, and/or a loss of functional potency
associated with prolonged tissue culture maintenance.
Although the combined stimulation of the BMMF with
IL-12 and IL-18 is required to stimulate IFN-g secretion,
both cytokines alone suffice in inducing detectable IFN-g
mRNA. Whether this difference reflects merely a limita-
tion of the ELISA sensitivity or hints towards unknown
posttranscriptional regulatory mechanisms remains to be
elucidated. Furthermore, Fultz et al. described the detec-
tion of IFN-g mRNA without secreted protein upon LPS
stimulation of various types of murine macrophages, in-
cluding BMMF (18), a finding we were unable to repro-
duce in the present study (not shown).
An interesting side-aspect of our work is the finding that
IL-12 and TNF-a, similar to their synergistic effects in the
induction of IFN-g by NK cells (19), also cooperate in the in-
duction of IFN-g secretion by BMMF. Among the three
strains tested, this effect is seen only in C57BL/6-BMMF,
possibly reflecting a genetic polymorphism related to the
known genetic differences between inbred mice in the
ability to generate Th1- or Th2-dominated immune re-
sponses. Thus, a detailed comparison of this phenomenon
between different mouse strains might prove fruitful.
Our work demonstrates for the first time that macrophages
secrete high levels of IFN-g upon combined stimulation
with IL-12 and IL-18. Upon appropriate activation by patho-
gens or LPS, macrophages are known to be important pro-
ducers of IL-12 (2) or IL-18 (3). Thus, our findings unravel
a novel potential pathway of autocrine macrophage activa-
tion involving endogenously produced IFN-g. This path-
way might play a pivotal role during early innate immune
reactions, i.e., before the development of adaptive immu-
nity, in infectious diseases (7, 10), in septic shock (3), as
well as during autoimmune reactions (20).
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